Radicava

Active Ingredient(s): Edaravone
FDA Approved: * May 5, 2017
Pharm Company: * MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA INC
Category: Neurological Disorders

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Radicava Overview

Edaravone, sold as under the brand names Radicava and Radicut, is an intravenous medication used to help with recovery following a stroke and to treat amyotrophic lateral sclerosis (ALS).[1][2] The label carries a warning about the potential for hypersensitivity reactions to edaravone, and adverse effects include bruising, gait disturbances, headache, skin inflammation, eczema, problems breathing, excess sugar in urine, and fungal skin infections.[1&...

Read more Radicava Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Edaravone

Recent Radicava Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Radicava: (2 results)

Sorted by National Drug Code

• 70510-2171 Radicava 30 mg/100ml Intravenous Injection by Mt Pharma America, Inc.
• 70510-2172 Radicava 60 mg/100ml Intravenous Injection by Mitsubishi Tanabe Pharma America, Inc.

Other drugs which contain Edaravone or a similar ingredient: (1 result)

• EDARAVONE